Will Scanning for Elevated Temperatures Really Become a Prerequisite for Doing Business?: Business Casual

 

As a response to the spread of the novel coronavirus and the ensuing COVID-19 pandemic, many operations have turned to elevated temperature scanning solutions to provide a screening method for their physical gathering spaces.

While the technology seems like a no-brainer on the surface, is it as beneficial as it sounds?

In some cases, handheld scanning still puts employees at risk. Further, the process is tremendously inefficient.

However, there could be a way forward.

Companies have turned their focus toward integrated solutions that combine with contactless kiosks and robust security systems and strategies, providing a path toward more meaningful and lasting solutions.

On this episode of Business Casual, hosts Voice of B2B Daniel Litwin, Tyler Kern and Taylor Bagley explore whether temperature scanning will actually become a brick-and-mortar mainstay, how these systems might have multiple functions, and more.

For the latest news, videos, and podcasts in the Building Management Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Latest

NRF 2022 Retail's Big Show
What’s in the Shopping Cart for the 2022 National Retail Federation’s Big Show?
January 14, 2022
 In just a few short days, from January 16th through the 18th, the National Retail Federation will launch Retail’s Big Show in the shopping capital of the world, New York City. As retail Read more
Schools Struggle to Reach Their Education Technology Goals. Here’s Why and How To Fix It.
January 14, 2022
As we hit the two-year mark of the COVID-19 pandemic, the education sector continues to struggle in adjusting to virtual and hybrid education at scale. In 2020, McKinsey estimated that, due to COVID Read more
85% of Clinical Drug Trials Face Delays. What's the True Cost?
85% of Clinical Drug Trials Face Delays. What’s the True Cost?
January 14, 2022
  Clinical trials can save lives and provide new ways to treat disease. The industry estimates that 85% of all clinical trials face delays due to patient enrollment. Understanding that challenge Read more